帕帕因和梅林与二进制和三进制系统中的阿皮基因和白色素的相互作用机制
Xiangrong Li1, Wanqing Xu2, Xianfei Liu3
1Department of Medical Chemistry, Xinxiang Engineering Technology Research Center of Functional Medical Nanomaterials, Key Laboratory of Medical Molecular Probes, School of Basic Medical Science, Xinxiang Medical University, Xinxiang, Henan 453003, PR China.
概括
像阿皮基宁和黄素这样的黄类化合物适度地与帕帕因和梅林酶结合. 它们的结合顺序影响了酶活性,三元系统表现出更强的抑制,特别是在帕帕因上.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 分子相互作用 分子相互作用
背景情况:
- 帕帕因和布罗梅林是具有重要的生物作用的囊蛋白酶.
- 原蛋白和黄素是具有潜在治疗性质的黄类.
- 了解它们的相互作用对于药物开发和酶抑制研究至关重要.
研究的目的:
- 为了研究帕帕因/布罗梅林和阿皮根因/卢托林之间的相互作用机制.
- 分析这些黄类素对酶构成和活性的影响.
- 为了比较二进制和三进制系统的相互作用及其抑制潜力.
主要方法:
- 使用了光谱方法 (例如光,UV-Vis).
- 进行了分子对接和分子动力学模拟.
- 进行了酶活性测定,以评估抑制.
主要成果:
- 原蛋白和黄素表现出适度的结合亲和力 (Ka: 10^4-10^5 L mol^-1) 与帕帕因和布罗梅林.
- 黄类添加的顺序影响了结合亲和力.
- 非共价力 (键,范德瓦尔斯,疏水,静电) 介导的相互作用.
- 黄类药物改变了酶微环境,二级/三级结构和活性.
- 三元系统比二元系统表现出更强的帕帕因抑制.
结论:
- 原蛋白和原蛋白通过各种非共价力与帕帕因和布罗梅林相互作用.
- 这些相互作用导致形状变化和酶活性改变.
- 黄酸酶相互作用取决于添加顺序和系统组成.
- 三级系统,特别是涉及黄素和原素,显示出显著的Papain抑制作用.
相关概念视频
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
155
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
155


